A Critical Re-Evaluation of "BRAIN-MAGNET: A Functional Genomics Atlas for Interpretation of Non-Coding Variants" by Deng et al., Cell 2025; doi:10.1016/j.cell.2025.10.029

This commentary provides a comprehensive and multidimensional critical evaluation of the landmark study “BRAIN-MAGNET: A Functional Genomics Atlas for Interpretation of Non-Coding Variants” by Deng et al., published in Cell (2025). The original paper introduces BRAIN-MAGNET as an integrative single-cell functional genomics atlas designed to decode the regulatory consequences of non-coding variants across diverse human brain cell types. While the study represents a major methodological and conceptual advance in neurogenomics, it also raises important questions regarding data completeness, computational interpretability, and translational relevance.

Our commentary systematically examines the strengths, innovations, limitations, and future opportunities of BRAIN-MAGNET across multiple analytical dimensions. We evaluate the foundational single-cell epigenomic datasets and highlight their contributions to cell-type-resolved enhancer mapping while noting gaps related to donor diversity, developmental coverage, and brain-region representation. The machine learning framework underlying variant impact prediction is discussed in depth, with explicit attention to training data constraints, interpretability challenges, and risks of overfitting. We also critique the reliance on computationally inferred enhancer–promoter interactions, emphasizing the need for expanded experimental validation.

A detailed figure-by-figure analysis scrutinizes the clarity, statistical rigor, and biological implications of all main figures, extended data figures, and supplementary materials. We highlight where visualization choices limit interpretability, where missing controls weaken conclusions, and where additional transparency is required to substantiate claims. The commentary also explores BRAIN-MAGNET’s applications to neurological and psychiatric disorders, discussing how the atlas aids in the interpretation of GWAS non-coding loci and offers new mechanistic hypotheses for neuronal dysfunction.

Broader implications for ethics, population diversity, and clinical translation are examined, underscoring the need for equitable regulatory genomic resources and caution in applying predictive models to clinical decision-making. The commentary concludes with recommendations for future directions, including multi-omics integration, longitudinal developmental atlases, high-throughput perturbation screens, and enhanced model transparency.

Overall, this critique aims to contextualize BRAIN-MAGNET within the rapidly evolving field of functional neurogenomics, offering constructive insights that may guide future iterations of regulatory atlases and advance our understanding of non-coding genetic variation in brain health and disease.